Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 5 studies | 35% ± 15% | |
endothelial cell | 4 studies | 21% ± 5% | |
astrocyte | 4 studies | 30% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 7% | |
epithelial cell | 4 studies | 27% ± 8% | |
oligodendrocyte | 4 studies | 23% ± 2% | |
Mueller cell | 3 studies | 21% ± 3% | |
GABAergic neuron | 3 studies | 38% ± 5% | |
glutamatergic neuron | 3 studies | 43% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 35% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1400.27 | 1445 / 1445 | 100% | 23.69 | 183 / 183 |
intestine | 100% | 3024.50 | 966 / 966 | 100% | 29.82 | 527 / 527 |
stomach | 100% | 1951.71 | 359 / 359 | 100% | 28.49 | 286 / 286 |
liver | 100% | 6074.95 | 226 / 226 | 100% | 30.81 | 404 / 406 |
lung | 99% | 1137.77 | 574 / 578 | 99% | 14.40 | 1139 / 1155 |
pancreas | 100% | 1267.17 | 328 / 328 | 98% | 16.44 | 174 / 178 |
breast | 100% | 1167.69 | 459 / 459 | 98% | 20.80 | 1091 / 1118 |
prostate | 100% | 1675.34 | 245 / 245 | 97% | 15.22 | 488 / 502 |
thymus | 100% | 1650.06 | 653 / 653 | 97% | 13.34 | 586 / 605 |
bladder | 100% | 1649.90 | 21 / 21 | 96% | 19.10 | 484 / 504 |
brain | 97% | 859.01 | 2575 / 2642 | 97% | 12.31 | 684 / 705 |
uterus | 100% | 1826.83 | 170 / 170 | 94% | 15.35 | 433 / 459 |
kidney | 100% | 1153.87 | 89 / 89 | 94% | 18.81 | 846 / 901 |
skin | 100% | 2286.89 | 1809 / 1809 | 93% | 13.97 | 438 / 472 |
ovary | 100% | 1817.73 | 180 / 180 | 85% | 8.09 | 364 / 430 |
adrenal gland | 100% | 1798.05 | 258 / 258 | 53% | 6.00 | 121 / 230 |
adipose | 100% | 1288.43 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1193.08 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.51 | 1 / 1 |
blood vessel | 100% | 1728.35 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1353.83 | 800 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 13.63 | 43 / 45 |
heart | 95% | 738.98 | 815 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 9.14 | 22 / 29 |
peripheral blood | 66% | 696.72 | 615 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 56% | 5.18 | 45 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015789 | Biological process | UDP-N-acetylgalactosamine transmembrane transport |
GO_0090481 | Biological process | pyrimidine nucleotide-sugar transmembrane transport |
GO_0015780 | Biological process | nucleotide-sugar transmembrane transport |
GO_1990569 | Biological process | UDP-N-acetylglucosamine transmembrane transport |
GO_0015787 | Biological process | UDP-glucuronic acid transmembrane transport |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005462 | Molecular function | UDP-N-acetylglucosamine transmembrane transporter activity |
GO_0015297 | Molecular function | antiporter activity |
GO_0005461 | Molecular function | UDP-glucuronic acid transmembrane transporter activity |
GO_0005463 | Molecular function | UDP-N-acetylgalactosamine transmembrane transporter activity |
Gene name | SLC35D1 |
Protein name | Nucleotide sugar transporter SLC35D1 (Solute carrier family 35 member D1) (UDP-galactose transporter-related protein 7) (UGTrel7) (UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter) (UDP-GlcA/UDP-GalNAc transporter) |
Synonyms | KIAA0260 UGTREL7 |
Description | FUNCTION: Antiporter that transports nucleotide sugars across the endoplasmic reticulum (ER) membrane in exchange for either their cognate nucleoside monophosphate or another nucleotide sugar . Transports various UDP-sugars including UDP-N-acetyl-alpha-D-glucosamine (UDP-GlcNAc), UDP-N-acetyl-alpha-D-galactosamine (UDP-GalNAc) and UDP-alpha-D-glucuronate (UDP-GlcA), which are used by ER glucosyltransferases as sugar donors for the synthesis of sugar chains of glycoproteins, glycolipids and oligosaccharides . May couple UDP-GlcNAc or UDP-GalNAc efflux to UDP-GlcA influx into the ER lumen that in turn stimulates glucuronidation and subsequent excretion of endobiotics and xenobiotics . Plays a role in chondroitin sulfate biosynthesis, which is important for formation of cartilage extracellular matrix and normal skeletal development (By similarity). . |
Accessions | ENST00000235345.6 [Q9NTN3-1] Q9NTN3 |